0      0

2022 AABB Annual Meeting

AM22-SN02-L - AM22-SN02-L: Ask the FDA and CMS/CLIA (Live)

Oct 2, 2022 8:30am ‐ Oct 2, 2022 9:30am

Credits: None available.


This annual event provides an opportunity for FDA and CMS/CLIA representatives to respond to member questions and present the agency's current thinking on policies, regulations, guidance documents and inspection programs that are relevant to the oversight of blood and HCT/P programs. Questions for the session are submitted in advance to regulatory@aabb.org.

Learning Objectives:
  • Evaluate existing practices to establish alignment with current regulatory requirements and recommendations.
  • Apply FDA's recommendations in recently issued guidance to industry.
  • Describe FDA's approach for blood and HCT/P policies, regulations and inspection programs.



  • Karen Palmer, MT(ASCP) CQA(ASQ) : Nothing to Disclose
  • Arnold McKinnon : Nothing to Disclose


Credits: None available.

You must be logged in and own this session in order to post comments.